Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 4489 to 4494 of 4494 entries
Sorted by: Best Match Show Resources per page
Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How?.

JAMA neurology

Czap AL, Grotta JC.
PMID: 33720276
JAMA Neurol. 2021 May 01;78(5):517-518. doi: 10.1001/jamaneurol.2021.0290.

No abstract available.

Cite
Czap AL, Grotta JC. Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How?. JAMA Neurol. 2021;78(5):517-518doi: 10.1001/jamaneurol.2021.0290.
Czap, A. L., & Grotta, J. C. (2021). Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How?. JAMA neurology, 78(5), 517-518. https://doi.org/10.1001/jamaneurol.2021.0290
Czap, Alexandra L, and Grotta, James C. "Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How?." JAMA neurology vol. 78,5 (2021): 517-518. doi: https://doi.org/10.1001/jamaneurol.2021.0290
Czap AL, Grotta JC. Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How?. JAMA Neurol. 2021 May 01;78(5):517-518. doi: 10.1001/jamaneurol.2021.0290. PMID: 33720276.
Copy Download .nbib Format: NLM
Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

International journal of molecular sciences

Carré J, Jourdi G, Gendron N, Helley D, Gaussem P, Darnige L.
PMID: 35008518
Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010093.

For more than 10 years, direct oral anticoagulants (DOACs) have been increasingly prescribed for the prevention and treatment of thrombotic events. However, their use in immunothrombotic disorders, namely heparin-induced thrombocytopenia (HIT) and antiphospholipid syndrome (APS), is still under investigation....

Cite
Carré J, Jourdi G, Gendron N, et al. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010093.
Carré, J., Jourdi, G., Gendron, N., Helley, D., Gaussem, P., & Darnige, L. (2021). Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010093
Carré, Julie, et al. "Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010093
Carré J, Jourdi G, Gendron N, Helley D, Gaussem P, Darnige L. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010093. PMID: 35008518.
Copy Download .nbib Format: NLM
Direct Oral Anticoagulants: A Delicate and Dynamic Balance.

Journal of cardiovascular pharmacology and therapeutics

Giordan M.
PMID: 34351804
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):739-740. doi: 10.1177/10742484211037764. Epub 2021 Aug 05.

No abstract available.

Cite
Giordan M. Direct Oral Anticoagulants: A Delicate and Dynamic Balance. J Cardiovasc Pharmacol Ther. 2021;26(6):739-740doi: 10.1177/10742484211037764.
Giordan, M. (2021). Direct Oral Anticoagulants: A Delicate and Dynamic Balance. Journal of cardiovascular pharmacology and therapeutics, 26(6), 739-740. https://doi.org/10.1177/10742484211037764
Giordan, Massimo. "Direct Oral Anticoagulants: A Delicate and Dynamic Balance." Journal of cardiovascular pharmacology and therapeutics vol. 26,6 (2021): 739-740. doi: https://doi.org/10.1177/10742484211037764
Giordan M. Direct Oral Anticoagulants: A Delicate and Dynamic Balance. J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):739-740. doi: 10.1177/10742484211037764. Epub 2021 Aug 05. PMID: 34351804.
Copy Download .nbib Format: NLM
Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis.

Pediatric neurology

Sánchez van Kammen M, Male C, Connor P, Monagle P, Coutinho JM, Lensing AWA.
PMID: 35032886
Pediatr Neurol. 2021 Dec 28;128:20-24. doi: 10.1016/j.pediatrneurol.2021.12.011. Epub 2021 Dec 28.

BACKGROUND: We aimed to describe the clinical presentation, risk of bleeding and recurrent thrombosis, and perioperative anticoagulant management of children with cerebral venous thrombosis (CVT) and an associated head or neck infection.METHODS: In this subgroup analysis of the EINSTEIN-Jr...

Cite
Sánchez van Kammen M, Male C, Connor P, et al. Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis. Pediatr Neurol. 2021;128:20-24doi: 10.1016/j.pediatrneurol.2021.12.011.
Sánchez van Kammen, M., Male, C., Connor, P., Monagle, P., Coutinho, J. M., Lensing, A. W. A. (2021). Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis. Pediatric neurology, 12820-24. https://doi.org/10.1016/j.pediatrneurol.2021.12.011
Sánchez van Kammen, Mayte, et al. "Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis." Pediatric neurology vol. 128 (2021): 20-24. doi: https://doi.org/10.1016/j.pediatrneurol.2021.12.011
Sánchez van Kammen M, Male C, Connor P, Monagle P, Coutinho JM, Lensing AWA. Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis. Pediatr Neurol. 2021 Dec 28;128:20-24. doi: 10.1016/j.pediatrneurol.2021.12.011. Epub 2021 Dec 28. PMID: 35032886.
Copy Download .nbib Format: NLM
A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium.

Cureus

Olagunju A, Khatib M, Palermo-Alvarado F.
PMID: 33777573
Cureus. 2021 Feb 22;13(2):e13486. doi: 10.7759/cureus.13486.

According to the ARISTOTLE trial, apixaban was superior to warfarin because it was associated with fewer strokes, systemic embolism, and bleeding. Hemopericardium was one of the major bleeding events reported in this trial. However, the percentage of patients that...

Cite
Olagunju A, Khatib M, Palermo-Alvarado F. A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus. 2021;13(2):e13486doi: 10.7759/cureus.13486.
Olagunju, A., Khatib, M., & Palermo-Alvarado, F. (2021). A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus, 13(2), e13486. https://doi.org/10.7759/cureus.13486
Olagunju, Abdulbaril, et al. "A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium." Cureus vol. 13,2 (2021): e13486. doi: https://doi.org/10.7759/cureus.13486
Olagunju A, Khatib M, Palermo-Alvarado F. A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus. 2021 Feb 22;13(2):e13486. doi: 10.7759/cureus.13486. PMID: 33777573; PMCID: PMC7990001.
Copy Download .nbib Format: NLM
The topical application of tranexamic acid to control bleeding in inguinal hernia surgery candidate patients: A randomized controlled trial.

Annals of medicine and surgery (2012)

Ghaffari Hamedani SMM, Akbari A, Sayaydi S, Zakariaei Z, Moosazadeh M, Boskabadi J, Naserifar M, Kargar Soliemanabad S.
PMID: 34429952
Ann Med Surg (Lond). 2021 Aug 10;69:102683. doi: 10.1016/j.amsu.2021.102683. eCollection 2021 Sep.

BACKGROUND AND OBJECTIVES: Inguinal hernia surgery is a common procedure, especially for the elderly, who usually use anticoagulants and antiplatelet drugs. In this study, we evaluated the effectiveness of tranexamic acid (TXA) on the complications of inguinal hernia repair...

Cite
Ghaffari Hamedani SMM, Akbari A, Sayaydi S, et al. The topical application of tranexamic acid to control bleeding in inguinal hernia surgery candidate patients: A randomized controlled trial. Ann Med Surg (Lond). 2021;69:102683doi: 10.1016/j.amsu.2021.102683.
Ghaffari Hamedani, S. M. M., Akbari, A., Sayaydi, S., Zakariaei, Z., Moosazadeh, M., Boskabadi, J., Naserifar, M., & Kargar Soliemanabad, S. (2021). The topical application of tranexamic acid to control bleeding in inguinal hernia surgery candidate patients: A randomized controlled trial. Annals of medicine and surgery (2012), 69102683. https://doi.org/10.1016/j.amsu.2021.102683
Ghaffari Hamedani, Seyed Muhammad Mehdi, et al. "The topical application of tranexamic acid to control bleeding in inguinal hernia surgery candidate patients: A randomized controlled trial." Annals of medicine and surgery (2012) vol. 69 (2021): 102683. doi: https://doi.org/10.1016/j.amsu.2021.102683
Ghaffari Hamedani SMM, Akbari A, Sayaydi S, Zakariaei Z, Moosazadeh M, Boskabadi J, Naserifar M, Kargar Soliemanabad S. The topical application of tranexamic acid to control bleeding in inguinal hernia surgery candidate patients: A randomized controlled trial. Ann Med Surg (Lond). 2021 Aug 10;69:102683. doi: 10.1016/j.amsu.2021.102683. eCollection 2021 Sep. PMID: 34429952; PMCID: PMC8365320.
Copy Download .nbib Format: NLM
Showing 4489 to 4494 of 4494 entries